← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

▼ SELL

$ Value

$757K

Shares

51,500

Price

$15

Filed

Jul 30

Insider

Name

Levy Adam Scott

Title

CFO and Secretary

CIK

0001693134

Roles

Officer

Transaction Details

Transaction Date

2025-07-30

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

141,359

Footnotes

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.20. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.01. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.06 to $15.06. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.063 to $15.130. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Filing Info

Accession No.

0001933414-25-000081

Form Type

4

Issuer CIK

0001933414

Levy Adam Scott's History

Date Ticker Type Value
2025-11-11 MLYS M $210K
2025-11-11 MLYS M $551K
2025-11-11 MLYS M $628K
2025-11-11 MLYS M $102K
2025-11-11 MLYS $43K
2025-11-11 MLYS $473K
2025-11-11 MLYS $67K
2025-11-11 MLYS $539K
2025-11-11 MLYS $359K
2025-11-11 MLYS $180K

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$621K 2026-04-17
Karydas Daphne $75K 2026-03-31